巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Prothena Corp

    PRTA
    28.180
    1.620
    6.10%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Prothena Corp - 延遲價格・最後更新於 27/05 12:14
    最高位
    28.280
    最低位
    26.260
    開市價
    --
    前收市價
    26.560
    成交量(千)
    12.68
    成交額(百萬)
    3.16
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    1,319.00
    市盈率
    18.660
    息率
    --
    差價
    --
    52週高低
    79.749 - 23.820
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Prothena Corp
    證券代碼
    PRTA.US
    所屬板塊
    Biotechnology
    公司業務
    Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
    發行量
    46685735
    公司總部
    77 Sir John Rogerson’s Quay, Block C, Grand Canal Docklands
    公司網址
    https://www.prothena.com
    公司電郵
    info@prothena.com
    公司電話
    +353 12362500
    暫無內容

    關於

    Prothena Corp(PRTA.US)所屬的行業板塊為Biotechnology。
    Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
    詳細公司背景可參考: https://www.prothena.com